CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase IB Dose Exploration Trial With MK-8628, a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Subjects With Selected Advanced Solid Tumors
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02698176
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:50.983934+00:00
- Published At
- 2018-11-05T00:00:00+00:00
- Record Updated At
- 2021-01-27
- Results Posted At
- 2018-11-05
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["NUT Midline Carcinoma (NMC)", "Triple Negative Breast Cancer (TNBC)", "Non-small Cell Lung Cancer (NSCLC)", "Castration-resistant Prostate Cancer (CRPC)"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-01-27"- protocolSection.identificationModule.nctId
"NCT02698176"- protocolSection.identificationModule.officialTitle
"A Phase IB Dose Exploration Trial With MK-8628, a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Subjects With Selected Advanced Solid Tumors"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-11-05"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.